View : 147 Download: 0

Effects of PDE4 gene polymorphisms on efficacy and adverse drug events of ritodrine therapy in preterm labor patients: a prospective observational study

Title
Effects of PDE4 gene polymorphisms on efficacy and adverse drug events of ritodrine therapy in preterm labor patients: a prospective observational study
Authors
Yee, JeongHwang, Han SungChung, Jee EunPark, Jin YoungLee, Kyung EunKim, Young JuGwak, Hye Sun
Ewha Authors
김영주곽혜선
SCOPUS Author ID
김영주scopus; 곽혜선scopus
Issue Date
2019
Journal Title
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
ISSN
0031-6970JCR Link

1432-1041JCR Link
Citation
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY vol. 75, no. 10, pp. 1379 - 1386
Keywords
RitodrinePreterm laborPhosphodiesterase 4D geneSingle nucleotide polymorphismTime to deliveryAdverse drug events
Publisher
SPRINGER HEIDELBERG
Indexed
SCIE; SCOPUS WOS scopus
Document Type
Article
Abstract
Purpose Phosphodiesterase (PDE) terminates the signaling pathway of myometrial relaxation by degradating cAMP to the inactive 5 '-AMP. The PDE4 family is one of the most predominant PDE families that display high affinity to cAMP. The objective of this study was to evaluate the effects of PDE4 gene polymorphisms on tocolytic effects and adverse drug events (ADEs) of ritodrine therapy in patients with preterm labor. Methods A total of 170 preterm labor patients were included in this study. To elucidate the effects of genetic polymorphisms on the inter-individual variability of ritodrine efficacy and ADEs, 8 single nucleotide polymorphisms (SNPs) were genotyped: PDE4D (rs1544791, rs983280, rs1504982, rs10940648, rs829259) and PDE4B2 (rs598961, rs2180335, and rs17128809). Additionally, rs1042719 of the ADRB2 gene was included for multivariate analysis. The primary endpoint of this prospective study was the time to delivery (hr). The secondary endpoint was ritodrine-induced ADEs. Results The mutant-type homozygote carriers of PDE4B2 rs598961 polymorphism showed shorter median time to delivery than those with other genotypes (adjusted hazard ratio 1.6, 95% confidence interval 1.0 to 2.4, P = 0.035). On the other hand, patients with wild-type homozygotes of PDE4B2 rs17128809 showed 2.6 similar to 2.9 times higher ADEs compared to those with other genotypes. Among demographic characteristics, gestational age at start of drug therapy and modified Bishop score were significant factors for time to delivery, whereas height, weight, and BSA were significant factors for ritodrine-induced ADEs after adjusting other factors. Conclusions This pharmacogenomic study suggested that PDE4 genetic polymorphisms impact individual susceptibility to beta 2-adrenergic receptor targeted therapy in patients with preterm labor.
DOI
10.1007/s00228-019-02719-9
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE